High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
30753492
DOI
10.1210/jc.2018-02288
PII: 5307690
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Genetic Predisposition to Disease epidemiology MeSH
- Genetic Variation * MeSH
- Cohort Studies MeSH
- Infant MeSH
- Humans MeSH
- Human Growth Hormone therapeutic use MeSH
- Metalloendopeptidases genetics MeSH
- Adolescent MeSH
- Growth Disorders drug therapy epidemiology genetics MeSH
- Child, Preschool MeSH
- Prognosis MeSH
- Prospective Studies MeSH
- Receptor, Fibroblast Growth Factor, Type 3 genetics MeSH
- Receptor, IGF Type 1 genetics MeSH
- Pedigree MeSH
- Growth Plate drug effects MeSH
- Exome Sequencing methods MeSH
- Severity of Illness Index MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- FGFR3 protein, human MeSH Browser
- IGF1R protein, human MeSH Browser
- Human Growth Hormone MeSH
- Metalloendopeptidases MeSH
- Receptor, Fibroblast Growth Factor, Type 3 MeSH
- Receptor, IGF Type 1 MeSH
CONTEXT: Familial short stature (FSS) is a term describing a growth disorder that is vertically transmitted. Milder forms may result from the combined effect of multiple genes; more severe short stature is suggestive of a monogenic condition. The etiology of most FSS cases has not been thoroughly elucidated to date. OBJECTIVES: To identify the genetic etiology of severe FSS in children treated with GH because of the diagnosis of small for gestational age or GH deficiency (SGA/GHD). DESIGN, SETTINGS, AND PATIENTS: Of 736 children treated with GH because of GHD/SGA, 33 with severe FSS (life-minimum height -2.5 SD or less in both the patient and shorter parent) were included in the study. The genetic etiology was known in 5 of 33 children prior to the study [ACAN (in 2], NF1, PTPN11, and SOS1). In the remaining 28 of 33, whole-exome sequencing was performed. The results were evaluated using American College of Medical Genetics and Genomics standards and guidelines. RESULTS: In 30 of 33 children (90%), we found at least one variant with potential clinical significance in genes known to affect growth. A genetic cause was elucidated in 17 of 33 (52%). Of these children, variants in growth plate-related genes were found in 9 of 17 [COL2A1, COL11A1, and ACAN (all in 2), FLNB, FGFR3, and IGF1R], and IGF-associated proteins were affected in 2 of 17 (IGFALS and HMGA2). In the remaining 6 of 17, the discovered genetic mechanisms were miscellaneous (TRHR, MBTPS2, GHSR, NF1, PTPN11, and SOS1). CONCLUSIONS: Single-gene variants are frequent among families with severe FSS, with variants affecting the growth plate being the most prevalent.
References provided by Crossref.org
Monogenic causes of familial short stature
Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene
Analysis of children with familial short stature: who should be indicated for genetic testing?
Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young